About Evolent
Evolent is a company based in Arlington (United States) founded in 2010 by Seth Blackley and Frank Williams. Evolent has raised $100 million across 1 funding round from investors including TPG, Advisory and UPMC Health Plan. The company has 4,500 employees. Evolent offers products and services including Oncology Solution, Cardiology Solution, and Musculoskeletal Solution. Evolent operates in a competitive market with competitors including Aledade, Lumeris, Arcadia, Aetion and Advantum Health, among others.
- Headquarter Arlington, United States
- Employees 4,500
- Founders Seth Blackley, Frank Williams
- Stage Public
- SectorsHealthcare
- Website evolent.com
- Social LinkedIn X Facebook
- Legal Name Evolent Health, Inc
- Annual Revenue₹252 Cr
FY 2023 · +35% YoY
- Net Profit₹26.25 Cr
FY 2023 · 10% margin
- EBITDA₹39.02 Cr
FY 2023 · 15% margin
- Total Equity Funding$100M (USD)
in 1 rounds
- Latest Funding Round$100M (USD), Series B
Sep 2013
- InvestorsTPG
& 2 more
- Employee Count4,500
Associated legal entities of Evolent
Evolent operates through Evolent Health International Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Evolent Health International Private Limited CIN U72900PN2016FTC158737 | Active | 10 Mar 2016 | Pune, Maharashtra | ₹252 Cr | 988 | 2 | View details |
Products & Services of Evolent
Evolent offers a comprehensive portfolio of products and services, including Oncology Solution, Cardiology Solution, and Musculoskeletal Solution.
Supports access to up-to-date treatment pathways for patients.
Ensures alignment with treatment and testing guidelines.
Increases high-value procedures in appropriate settings.
Funding Insights of Evolent
Evolent has successfully raised a total of $100M through 1 strategic funding round. The most recent funding activity was a Series B round of $100 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100M
- Total Rounds 1
- Last Round Series B — $100M
- First Round $100M
(Sep 2013)
- Investors Count 3
All 1 funding rounds of Evolent with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $100M | Series B | – | Advisory, UPMC Health Plan | – |
3 investors in total: 3 institutional.
Investors in Evolent
Evolent has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include TPG, Advisory and UPMC Health Plan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Analytics platforms and consulting services for business intelligence are offered. | 1979 | advisory.com | - | |
Delivers comprehensive healthcare insurance services. | 1996 | upmchealthplan.com | Pittsburgh, United States |
Investor details for Evolent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Evolent Health International Private Limited (Evolent)
Evolent Health International Private Limited is the primary company behind Evolent. The board of Evolent Health International Private Limited currently have 2 directors; the longest-serving is Nikhil Ulhas Damle, appointed in 2018. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nikhil Ulhas Damle DIN 08163421 | Director | 25 Jun 2018 | 8 yrs 3 mo | Evolent Health International Private Limited |
| Hemant Yashwant Zunjarrao DIN 10828858 | Director | 04 Dec 2024 | 1 yr 10 mo | Evolent Health International Private Limited |
People of Evolent
313 people are tracked at Evolent (180 in leadership, 9 in board & advisors, 124 in team); the tracked headcount is 4,500.
| Name | Role | Group |
|---|---|---|
Seth Blackley | Co-Founder & CEO | Leadership |
Frank Williams | Co-Founder | Leadership |
Morgan Rogers | Director, Strategic Accounts | Leadership |
Kelsie Fox | Senior Director, Total Rewards | Leadership |
Saagar Vadge | Associate Director Total Rewards And Operations | Leadership |
John Tam | Chief Strategy Officer | Leadership |
Fernando Villacian | Senior Medical Director, Cardiovascular, New Century Health | Leadership |
John Johnson | CFO | Leadership |
Mario Santos | Director, Risk Adjustment And Quality Analytics | Leadership |
Luisa C. | Director, Partner Operations | Leadership |
Katie Maher | Senior Director, Clinical Operations | Leadership |
Von Nguyen | Chief Medical Officer | Leadership |
Jeffrey Wise | Chief Medical Director Musculoskeletal And Spinal Surgery | Leadership |
Ravleen Wahan | Associate Director Product Management | Leadership |
Samantha Rappa | Director | Leadership |
Andrew Hertler | Chief Medical Officer, New Century Health | Leadership |
Nicole Wilson | Director Of Clinical Programs - Oncology | Leadership |
Craig L. Dietrich | Director | Leadership |
Mario R. | Chief Financial Officer | Leadership |
Mary Beach | Managing Director, Compliance | Leadership |
293 more people are available in the full profile.
Complete people profiles for Evolent
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Evolent
Evolent is a publicly listed company on the NYSE with ticker symbol EVH in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Jun 2015
- Listed onNYSE: EVH
- Listed entityEvolent Health, Inc
- Exchange sectorCommercial services
- ISINUS30050B1017
- Share price$4.04 (+2.02% on the day) · 2026-10-09
- Market capitalisation$456.8M
- EPS (diluted, trailing year)$-4.57
- Volume (last session)1,068,784
Financials of Evolent
Figures of Evolent Health International Private Limited, the primary company behind Evolent, for FY 2023. Revenue was ₹252 Cr (+35% year on year). Net profit was ₹26.25 Cr (10% margin). EBITDA was ₹39.02 Cr (15% margin). Revenue has grown at a compounded annual rate of +47% over three years and +71% over five years.
- ₹252 CrRevenue · FY 2023 · +35% YoY
- ₹26.25 CrNet profit · 10% margin
- ₹39.02 CrEBITDA · 15% margin
- ₹5 LakhPaid-up capital
- 988Employees (provident fund records)
- +47%Revenue CAGR, 3 years
- +71%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.88B | -$534.5M | $111.4M |
| 2024 | $2.55B | -$61.6M | $125.5M |
| 2023 | $1.96B | -$113.0M | $154.2M |
| 2022 | $1.35B | -$18.7M | $95.3M |
| 2021 | $908.0M | -$30.8M | $42.6M |
Balance sheet, profit and loss, cash flow and ratios of Evolent Health International Private Limited are on its company page.
Detailed financial statements for Evolent
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Evolent
3 dated milestones of Evolent across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Evolent is founded.
- Funding First funding round of $100.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Evolent
Evolent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aledade, Lumeris, Arcadia, Aetion and Advantum Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aledade.com | 2014 | Bethesda, United States | $780.49M | 1,346 | Primary care physician platform for patient care delivery is provided. | |
| lumeris.com | 2001 | Maryland Heights, United States | $477.3M | 1,375 | Lumeris offers population management and accountable care solutions | |
| arcadia.io | 2002 | Boston, United States | $72.5M | 409 | AI-based healthcare data analytics platform is provided for organizations. | |
| aetion.com | 2012 | New York, United States | $203.6M | – | Provides payer/provider, biopharma and medical device customers with a platform to allow them to gain insights into the clinical and financial status of a population | |
| advantumhealth.com | 2013 | Louisville, United States | – | 413 | Healthcare providers are supported in shifting to value-based care models. | |
| wellcentive.com | 2005 | Alpharetta, United States | $18.48M | 106 | Providing cloud-based population health management and data analytic solutions for HCOs | |
| hoppen.care | 2011 | Cesson Sevigne, France | $35.25M | – | Digital health tools are provided for hospital care management systems. | |
| truvenhealth.com | 2012 | Ann Arbor, United States | – | 54,912 | Healthcare analytics and data integration solutions are delivered. | |
| citrahealth.com | 2012 | Jacksonville, United States | $22.5M | – | IT solutions are provided for healthcare payers and providers. |
Detailed competitors of Evolent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Evolent
The website of Evolent (evolent.com) receives about 35K visits a month.
- Monthly visits35K
▼ 52% vs previous month
Websites whose visitors overlap most with Evolent. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
modernhealthcare.com | modernhealthcare.com | 100% | – | #215,566 | – |
evolent.sharepoint.com | evolent.sharepoint.com | 33% | – | – | – |
| youtube.com | 29% | 30.4B | #2 | View details |
Latest news on Evolent
Complete news archive for Evolent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Evolent
10 companies that operate in the same segment as Evolent (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evolent
Evolent was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Evolent is headquartered in Arlington, United States. It is registered at Arlington, Virginia, United States.
Seth Blackley is the current CEO of Evolent. They have also founded this company.
Evolent is a funded company, having raised a total of $100M across 1 funding round to date. The company's 1st funding round was a Series B of $100M, raised on Sep 2013.
Evolent has 4,500 employees.
The primary company behind Evolent, Evolent Health International Private Limited, reported revenue of ₹252 Cr for FY 2023, up 35% year on year.
Evolent was founded in 2010 and is headquartered in Arlington, United States. Operations center on the healthcare sector, where intelligent solutions are provided for managing complex conditions. Partnerships with health plans and physicians are established to support healthcare transformation. Better outcomes are targeted for individuals facing intricate health needs, with services encompassing advisory and technology integrations across the U.S.
Evolent offers Oncology Solution, Cardiology Solution, and Musculoskeletal Solution.
Yes, Evolent is publicly traded on NYSE under the ticker symbol EVH.
Evolent has 3 investors. Key investors include TPG, Advisory, and UPMC Health Plan.
Evolent operates through Evolent Health International Private Limited.